Walgreens Boots Alliance (NASDAQ:WBA – Free Report) had its price target raised by Royal Bank of Canada from $9.00 to $12.00 in a report issued on Wednesday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmacy operator’s stock.
A number of other equities analysts also recently commented on WBA. UBS Group lifted their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Morgan Stanley dropped their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. Evercore ISI raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday. Finally, TD Cowen reduced their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $13.04.
Walgreens Boots Alliance Trading Up 2.4 %
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the previous year, the firm earned $0.66 earnings per share. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. Sell-side analysts anticipate that Walgreens Boots Alliance will post 1.52 EPS for the current fiscal year.
Walgreens Boots Alliance Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.98%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.77%.
Institutional Investors Weigh In On Walgreens Boots Alliance
A number of institutional investors have recently added to or reduced their stakes in the company. First Financial Corp IN raised its stake in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares in the last quarter. TD Private Client Wealth LLC boosted its holdings in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 3,208 shares in the last quarter. Sentry Investment Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at $30,000. Eastern Bank purchased a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth about $33,000. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in shares of Walgreens Boots Alliance during the 2nd quarter valued at about $34,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
- Five stocks we like better than Walgreens Boots Alliance
- Best Stocks Under $5.00
- 3 Cheap Small-Cap Banks for Dividend Growth Investors
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- Where Do I Find 52-Week Highs and Lows?
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.